32 results
424B3
ATXI
Avenue Therapeutics Inc
28 Jun 23
Prospectus supplement
4:56pm
is a part is declared effective by the SEC;
through the writing or settlement of options or other hedging transactions, whether through an options … of this prospectus.
In connection with the sale of our Common Stock or interests therein, the Selling Stockholders may enter into hedging transactions
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
“derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various … times during the period that the Securities are outstanding, and (z) such hedging activities (if any) could reduce the value of the existing stockholders
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
is declared effective by the SEC;
through the writing or settlement of options or other hedging transactions, whether through an options exchange … of this prospectus.
In connection with the sale of our Common Stock or interests therein, the Selling Stockholders may enter into hedging transactions with broker
424B3
ATXI
Avenue Therapeutics Inc
4 May 23
Prospectus supplement
4:30pm
the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
a combination of any such methods … or interests therein, the Selling Stockholder may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn
424B3
i3kn48qvhc37hoqj0q
10 May 24
Prospectus supplement
4:53pm
8-K
EX-10.5
324h87gj
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
DEF 14C
4thllr18 16201m9
18 Mar 24
Information statement
4:59pm
PRE 14C
t5sefoys9ahxvssvxta
8 Mar 24
Preliminary information
4:31pm
10-K
h0k3ufeg43ixvpy zs
1 Mar 18
Annual report
12:00am